Approval · Notice of Compliance 8482 · 2006
HYCAMTIN: Notice of Compliance 8482
Issued December 21, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8482
- Date
- December 21, 2006
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the dosage and administration, drug interactions, and warnings and precautions sections of the product monograph
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYCAMTIN | Not yet assigned | — |
Medicinal ingredients
- TOPOTECAN HYDROCHLORIDE 4 MG per VIAL